Explanipedia

Outcomes and costs in specialized burn care: Adapting the Quality Cost Indicator (QCI) model for burn care Open

Raaba S. M. Thambithurai, Willem H. P. van Veghel, Denise van Uden, Jean-Bart Bügel, Anouk Pijpe , et al. · 2025

The Quality Cost Indicator (QCI) model supports value-based health care at the institutional level, by calculating disease-specific health outcomes per unit cost over time. The aim of this study was to adapt the QCI model for specialized b…

Tapering in Rheumatoid Arthritis: A Path to Predict Flares Open

Elise van Mulligen, Jon T. Giles, A. Weel · 2025

Sacroiliac damage on MRI in axial spondyloarthritis and chronic back pain, women with postpartum back pain, runners and healthy subjects Open

Zohra Kerami, Marleen van de Sande, K. M. Fagerli, Roberta Ramonda, A. Weel , et al. · 2025

Objective To investigate the extent and performance of structural lesions in sacroiliac joints on MRI (MRI-SI) in patients with axial spondyloarthritis (axSpA), chronic back pain, postpartum back pain, runners and healthy subjects. Methods…

How Do Bundled Payment Initiatives Account for Differences in Patient Risk Profiles? A Systematic Review Open

C.M.J. Hendriks, Fiona Koster, Daniëlle Cattel, Marc R. Kok, A. Weel , et al. · 2024

BP initiatives use various approaches to account for PRP differences. Despite a trend toward more sophisticated approaches, most remain basic with room for improvement. To enable cross-initiative comparisons and learning, it is important t…

Impact of musculoskeletal joint complaints on quality of life in patients with inflammatory bowel disease: a cross-sectional study Open

Maha Jamal, M.C. Karreman, Frederieke de Bruijne, T. Martijn Kuijper, Johanna M W Hazes , et al. · 2024

Background Musculoskeletal joint complaints (MSCs) are the most common extraintestinal manifestation of inflammatory bowel disease (IBD). We aimed to investigate the effect of MSC on the health-related quality of life (QoL) in patients wit…

Is the QCI framework suited for monitoring outcomes and costs in a teaching hospital using value-based healthcare principles? A retrospective cohort study Open

Willem van Veghel, Suzanne C. van Dijk, T.M.A.L. Klem, A. Weel, Jean-Bart Bügel , et al. · 2024

Objectives The objective is to develop a pragmatic framework, based on value-based healthcare principles, to monitor health outcomes per unit costs on an institutional level. Subsequently, we investigated the association between health out…

Development of a value-based healthcare burns core set for adult burn care Open

Inge Spronk, Denise van Uden, Corine A. Lansdorp, Lotte van Dammen, R. van Gemert , et al. · 2024

Capturing Patient Value in an Economic Evaluation Open

Fiona Koster, Marc R. Kok, Deirisa Lopes Barreto, A. Weel · 2023

Objective Economic evaluations predominantly use generic outcomes, such as the Euro Quality of Life‐5 Dimension (EQ‐5D), to assess health status. However, because of the generic nature, they are less suitable to capture the quality of life…

A trial-based economic evaluation of the CaFaSpA referral strategy for axial spondyloarthritis Open

Maha Jamal, T. Martijn Kuijper, J. M. W. Hazes, Deirisa Lopes Barreto, A. Weel · 2023

To assess the cost–utility from healthcare and societal perspectives of the digital CaFaSpA referral strategy (CS) for axial spondyloarthritis (axSpA) in primary care patients with chronic low back pain (CLBP). A cluster randomized control…

Cost–utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands Open

Luuk van Esveld, Juul M. Cox, T. Martijn Kuijper, Tessa M. Bosch, A. Weel · 2023

POS0989-HPR REAL-WORLD INDUCTION DMARD THERAPY IN RHEUMATOID ARTHRITIS; INSIGHTS IN THE DUTCH SANTEON BENCHMARK FRAMEWORK TO IMPROVE PATIENT CARE Open

Annerieke van Groenestijn, A.B.G. Kwast, Silke Van Lint, Leonard van Lier, Christopher Storck , et al. · 2023

Background Methotrexate (MTX) is the cornerstone therapy for rheumatoid arthritis (RA) patients, with well-established safety and efficacy profiles and support in international guidelines. Guidelines state that the maximal effect of MTX in…

Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based Costing Open

Fiona Koster, Marc R. Kok, Jaco van der Kooij, Geeke Waverijn, A. Weel , et al. · 2023

Arthroscopic synovectomy versus intra-articular injection of corticosteroids for the management of refractory psoriatic or rheumatoid arthritis of the wrist: study protocol for a randomized controlled trial (ARCTIC trial) Open

Philip N. d'Ailly, C. Deugd, N.W.L. Schep, T. Martijn Kuijper, Marc R. Kok , et al. · 2023

Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centered versus population-based comparison Open

Fiona Koster, Pieter Bakx, Marc R. Kok, Deirisa Lopes Barreto, A. Weel · 2023

The prevalence of multimorbidity among rheumatoid arthritis (RA) patients is increasing and associated with worse outcomes. Therefore, management of multimorbid patients requires a multidisciplinary approach. However, healthcare systems co…

EE118 Capturing Patient Value in an Economic Evaluation Open

Fiona Koster, Deirisa Lopes Barreto, Marc R. Kok, A. Weel · 2022

Barriers and facilitators for implementation of a digital referral algorithm for inflammatory arthritis - a qualitative assessment in patients and caregivers Open

Elke van Delft, Ruben Bos, Patricia Pennings, M. Hazes, Deirisa Lopes Barreto , et al. · 2022

Quality cost indicator: Reassessing the effects of health outcomes on healthcare expenditure. A retrospective cohort study Open

Willem H. P. van Veghel, S. Boon, T.M.A.L. Klem, A. Weel, JB Bugel , et al. · 2022

Background: Healthcare expenditure has increased rapidly over the last decades. Despite conceptual differences, healthcare expenditure and health outcomes play a significant role in Cost Effectiveness Analysis (CEA) and Value Based Health …

Defining the care delivery value chain and mapping the patient journey in rheumatoid arthritis Open

Fiona Koster, Deirisa Lopes Barreto, Sandhya Nair, Marc R. Kok, A. Weel · 2022

A systematic review on time trend incidence of rheumatoid arthritis in outpatient rheumatology clinics Open

E. Van Delft, Maha Jamal, Hannah den Braanker, T. Martijn Kuijper, J. M. W. Hazes , et al. · 2022

Objectives To classify patients with rheumatoid arthritis (RA) in an earlier stage of the disease, the ACR/EULAR classification criteria were updated in 2010. These criteria might have led to an increased incidence of RA in the rheumatolog…

Correction to: The impact of different (rheumatoid) arthritis phenotypes on patients’ lives Open

Nathalie Luurssen‐Masurel, A. Weel, Johanna Maria Wilhelmina Hazes, Pascal H P de Jong · 2022

Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients Open

Nathalie Luurssen‐Masurel, Elise van Mulligen, A. Weel, Johanna Maria Wilhelmina Hazes, Pascal H P de Jong · 2022

Diagnostic Performance and Clinical Utility of Referral Rules to Identify Primary Care Patients at Risk of an Inflammatory Rheumatic Disease Open

E. Van Delft, Deirisa Lopes Barreto, Annette H M van der Helm–van Mil, Celina Alves, Johanna Maria Wilhelmina Hazes , et al. · 2021

Objective To determine the diagnostic performance and clinical utility of the Rotterdam Early Arthritis Cohort (REACH) and the Clinical Arthritis Rule (CARE) referral rules in an independent population of unselected patients from primary c…

Progression From Subclinical Inflammation to Overt Spondyloarthritis in First‐Degree Relatives of Patients in Association With HLA–B27: The Pre‐Spondyloarthritis Cohort Open

Henriëtte M. Y. de Jong, Janneke J. H. de Winter, Irene E. van der Horst‐Bruinsma, D. van Schaardenburg, F. van Gaalen , et al. · 2021

Objective As first‐degree relatives (FDRs) of HLA–B27–positive patients with axial spondyloarthritis (SpA) have an increased risk of developing axial SpA, the objectives were 1) to evaluate the presence of highly specific imaging features …

POS0261 DIAGNOSTIC PERFORMANCE AND CLINICAL UTILITY OF TWO REFERRAL RULES FOR INFLAMMATORY ARTHRITIS Open

E. Van Delft, Deirisa Lopes Barreto, A. Van der Helm – van Mil, Celina Alves, J. M. W. Hazes , et al. · 2021

Factors that influence biological survival in rheumatoid arthritis: results of a real-world academic cohort from the Netherlands Open

Elise van Mulligen, Saad Ahmed, A. Weel, Johanna M. W. Hazes, Annette H M van der Helm–van Mil , et al. · 2021

CL3 Efficiency of Triage By a Rheumatologist in Primary Care for Patients Suspect for Inflammatory Arthritis: Preliminary Results Open

E. Van Delft, K. H. Han, Johanna M W Hazes, Deirisa Lopes Barreto, A. Weel · 2020

The number of risk factors for persistent disease determines the clinical course of early arthritis Open

Nathalie Luurssen‐Masurel, A. Weel, Gonul Hazal Koc, Johanna M. W. Hazes, Pascal H P de Jong · 2020

Objectives Management of early arthritis is based upon early recognition of individuals at high risk of developing persistent arthritis. Therefore, this study investigates whether the number of risk factors for persistent disease or treatm…

OP0279 THE IMPACT OF A REFERRAL STRATEGY FOR AXIAL SPONDYLOARTHRITIS: 12 MONTHS FOLLOW-UP OF PATIENT REPORTED OUTCOMES Open

M. J. Abdelkadir, T. Martijn Kuijper, Cathelijne Appels, Anneke Spoorenberg, J. Hazes , et al. · 2020

OP0282 COST-EFFECTIVENESS ANALYSIS OF A CAFASPA REFERRAL MODEL FOR AXIAL SPONDYLOARTHRITIS Open

M. J. Abdelkadir, T. Martijn Kuijper, Cathelijne Appels, Anneke Spoorenberg, Johanna M W Hazes , et al. · 2020

OP0281 TWO-YEAR COST-EFFECTIVENESS BETWEEN TWO GRADUAL TAPERING STRATEGIES IN RHEUMATOID ARTHRITIS: COST-UTILITY ANALYSIS OF THE TARA TRIAL Open

Elise van Mulligen, A. Weel, T. Martijn Kuijper, J. M. W. Hazes, Pascal H P de Jong · 2020

A. Weel YOU? Author Swipe